In any case, the important role of TRPV4 in osteoclast differentiation has been identified and more treatments for osteoclast abnormalities, such as RA or osteoporosis, could be developed, targeting TRPV4 in the future. The gene discussed is TRPV4; the disease is rheumatoid arthritis.